Brief: RenovoRx Strengthens IP Portfolio With Eighth U.S. Patent
05/01/2023 14:27
Jan 5 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX STRENGTHENS INTELLECTUAL PROPERTY (IP) PORTFOLIO
WITH
EIGHTH US PATENT
* RENOVORX INC - PATENT BROADLY COVERS METHODS FOR TREATING
BILE
DUCT CANCER
Source text for Eikon: ID:nBw5V7dt5a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer